Pooja Toshniwal Paharia

Pooja Toshniwal Paharia

M.D.S (OMR) - Masters in Dental Surgery (Oral Medicine and Radiology)

Oral Medicine, Radiology

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders. Her expertise involves diagnosing and managing potentially malignant as well as malignant lesions and conditions, temporomandibular joint disorders, orofacial pain conditions, salivary gland disorders, developmental anomalies, dental management of systemic conditions and medical emergencies, etc. using conservative treatments inclusive of medications, physiotherapy, biofeedback coupled gold standards such as surgical excisions and advanced techniques such as low-level laser therapy and transcutaneous electric nerve stimulation.

See more

During her post-graduation, she received accolades at several national and international conferences for her scientific research papers and the Academic Excellence Award for two consecutive years at her educational institute. Her field of interest has always been the use of advanced and non-invasive novel diagnostic as well as therapeutic techniques for maxillofacial disorders to provide an improved standard of care to patients. She has worked extensively on several research projects based on molecular spectroscopic analysis of proteins and nucleic acids and radiological assessment of morphological alterations correlated with disease severity in potentially malignant conditions. She has also worked on systematic reviews on the immunological management of Sjogren’s syndrome using novel monoclonal antibodies. As part of her post-graduation curriculum, she has undertaken several scientific writing assignments based on weekly reviews of constantly updated scientific literature published in peer-reviewed medical journals.

She is currently working as a consultant oral and maxillofacial radiologist at an advanced dental diagnostic center in India and provides three-dimensional and accurate radiological diagnostic information to doctors and patients on several dental conditions. Pooja is passionate about writing and dental health. Outside of work, she enjoys art, music, traveling, reading, and cooking.

See less

Articles from Pooja Toshniwal Paharia

Novel SARS-CoV-2 strains found to have low impact on CD8 T lymphocytes

Novel SARS-CoV-2 strains found to have low impact on CD8 T lymphocytes

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

CASCADE biosensor found to be effective in naked-eye SARS-CoV-2 RNA detection

CASCADE biosensor found to be effective in naked-eye SARS-CoV-2 RNA detection

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Study evaluates the prevalence of autoantibodies targeting type I interferons in critically-ill COVID-19 patients

Researchers study COVID-19-associated loss of life expectancy among Native Americans

Researchers study COVID-19-associated loss of life expectancy among Native Americans

Length of stay distributions of hospitalized COVID-19 cases during a mixed Omicron-Delta epidemic in Australia

Length of stay distributions of hospitalized COVID-19 cases during a mixed Omicron-Delta epidemic in Australia

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.